Christos Stelios Karapetis Selected Research

isopropyl-beta-galactopyranoside

8/2022	Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study).
1/2019	Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christos Stelios Karapetis Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2019
2	Adenocarcinoma 08/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 08/2022 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 08/2022 - 01/2019
2	Rectal Neoplasms (Rectal Cancer) 12/2019 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Osteoporosis 01/2021
1	Malignant Pleural Effusion 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Premature Menopause 01/2021
1	Inflammation (Inflammations) 12/2019
1	Ascites 01/2019
1	Sepsis (Septicemia) 01/2019
1	Hepatitis 01/2003
1	Hepatitis B 01/2003
1	Chronic Hepatitis B 01/2003

Drug/Important Bio-Agent (IBA)

2	isopropyl-beta-galactopyranosideIBA 08/2022 - 01/2019
2	human ERBB2 proteinIBA 08/2022 - 01/2019
2	Capecitabine (Xeloda)FDA Link 08/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2022 - 01/2019
1	NivolumabIBA 01/2022
1	CurcuminIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2019
1	Simvastatin (Zocor)FDA LinkGeneric 12/2019
1	indolepropanol phosphate (IPP)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	Gemcitabine FDA Link 01/2003
1	NucleosidesIBA 01/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 01/2003
2	Therapeutics 01/2021 - 01/2019
2	Radiotherapy 01/2019 - 01/2019
1	Immunotherapy 01/2022
1	Catheters 01/2021
1	Palliative Care (Palliative Therapy) 01/2021
1	Chemoradiotherapy 12/2019
1	Time-to-Treatment 01/2019
1	Treatment Delay 01/2019